Article info

Original research
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice

Authors

  1. Correspondence to Dr Claudia Gravekamp; claudia.gravekamp{at}einsteinmed.org; Dr Ilse Rooman; irooman{at}vub.be
View Full Text

Citation

Selvanesan BC, Meena K, Beck A, et al
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice

Publication history

  • Accepted September 29, 2020
  • First published November 5, 2020.
Online issue publication 
November 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.